Nature Medicine
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Randomised trial in 284 peopleType 2 diabetes
Papers by Qifu Li
3 results
- Diabetes/metabolism Research and Reviews
Long-Term Mortality in Diabetic Foot Disease is Higher Than That of Overall Cancer: Results From Three International Cohorts
Study in peoplePopulations - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Oral Small Molecule GLP-1RA in Chinese Obese Adults without Diabetes
Trial in peopleInterventions